Safety and Efficacy of Cunermuspir on Energy, Strength, and Fatigue in Patients With Nerve or Muscle Pain
Phase 1
Completed
- Conditions
- NeuralgiaMyalgia
- Interventions
- Drug: CunermuspirOther: Placebo
- First Posted Date
- 2021-02-03
- Last Posted Date
- 2021-04-20
- Lead Sponsor
- Mitosynergy LLC
- Target Recruit Count
- 56
- Registration Number
- NCT04737278
- Locations
- 🇨🇦
KGK Synergize now KGK Science, London, Ontario, Canada
© Copyright 2025. All Rights Reserved by MedPath